Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2020/183457CANNABINOID COMBINATIONS FOR TREATING DIABETIC NEUROPATHY
WO 17.09.2020
Int.Class A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
Appl.No PCT/IL2020/050272 Applicant BOL PHARMA LTD. Inventor GEDO, Tamir
The present invention is directed to a cannabinoid combination comprising, as the only cannabinoids, cannabidiol (CBD) and A9-tetrahydrocannabinol (THC), or enantiomers, diastereomers, or racemates thereof, for use in the treatment of diabetic neuropathy in a subject, or for improving the efficacy and/or reducing adverse effects of a standard of care (SoC) drug for treating neuropathic pain, wherein the CBD:THC weight ratio in the cannabinoid combination is about of 4:1 to about 10:1.
2.WO/2020/182596DOSAGE FORM COMPRISING A POLYMERIC MATRIX
WO 17.09.2020
Int.Class A61K 9/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
Appl.No PCT/EP2020/055810 Applicant EVONIK OPERATIONS GMBH Inventor MOERS, Christian
The invention is concerned with a dosage form, comprising a polymeric matrix, comprising one or more polymer(s) and a biologically active ingredient, wherein the polymeric matrix comprises 10 % by weight or more of the one or more polymer(s) and wherein the one or more polymer(s) are polymerized from a monomer mixture comprising the monomers (a) 70 to 95 % by weight of 2-ethylhexyl methacrylate (EHMA) and ethyl methacrylate (EMA) or 2-ethylhexyl methacrylate (EHMA) and methyl methacrylate (MMA), (b) 0 to 25 % by weight of a C2 to C6 hydroxy-alkylester of acrylic acid or methacrylic acid, (c) 2.5 to 20 % by weight of a C2 to C8 alkyl ester of acrylic acid or of methacrylic acid with a quaternary cationic group in the alkyl group.
3.WO/2020/183386DRINK ADDITIVE POINT OF USE ARTICLE OF MANUFACTURE
WO 17.09.2020
Int.Class A23L 33/105
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
105Plant extracts, their artificial duplicates or their derivatives
Appl.No PCT/IB2020/052146 Applicant RADIENT TECHNOLOGIES INNOVATIONS INC. Inventor SPLINTER, Steven
A method and system for selecting a plurality of elements of a cannabis consumable including receiving a match request at a beverage server via a communications network; obtaining a set of parameters from one of a plurality of databases stored on a memory of the beverage server corresponding to beverages and cannabis extracts; and determining, via the matching algorithm, a match for a cannabis consumable including a beverage and a cannabis extract. The methods and systems further include accessing an encapsulation database to retrieve encapsulation device parameters; and selecting the encapsulation device most suited to maintaining separation between the cannabis extract and the beverage and prevent degradation of active ingredients.
4.WO/2020/183436DOSAGE FORMS FOR ORAL DELIVERY OF CANNABINOIDS, METHOD OF PREPARATION AND USES OF SAME
WO 17.09.2020
Int.Class A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
Appl.No PCT/IB2020/052334 Applicant ONE WORLD CANNABIS LTD. Inventor SINAI, Alon
A solid dosage form for release of cannabinoids to the oral cavity are provided, the solid dosage form comprising a mixture of at least one cannabinoid, for example, cannabidiol (CBD) and/or tetrahydrocannabinol (THC), and at least one organic acid. The solid dosage form has a disintegration rate sufficient to allow at least one of buccal or sublingual absorption of the released cannabinoids. A process for preparation of a solid dosage form, e.g., a tablet. is provided.
5.WO/2020/183456CANNABINOID COMBINATIONS FOR TREATING CHRONIC PAIN IN DIALYSIS PATIENTS
WO 17.09.2020
Int.Class A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
Appl.No PCT/IL2020/050271 Applicant BOL PHARMA LTD. Inventor GEDO, Tamir
The present invention is directed to a cannabinoid combination comprising, as the only cannabinoids, cannabidiol (CBD) and A9-tetrahydrocannabinol (THC), or enantiomers, diastereomers, or racemates thereof, for use in the treatment of chronic pain and associated symptoms in a subject suffering from end-stage renal disease (ESRD) and treated with dialysis, or for improving the efficacy and/or reducing adverse effects of at least one analgesic used for treating pain in a subject suffering from ESRD and treated with dialysis, wherein the CBD:THC weight ratio in the cannabinoid combination is about of 4:1 to about 10:1, preferably about 6:1.
6.WO/2020/183455CANNABINOID COMBINATIONS FOR TREATING LOW BACK PAIN
WO 17.09.2020
Int.Class A61K 31/05
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
Appl.No PCT/IL2020/050270 Applicant BOL PHARMA LTD. Inventor GEDO, Tamir
The present invention is directed to a cannabinoid combination comprising, as the only cannabinoids, cannabidiol (CBD) and A9-tetrahydrocannabinol (THC), or enantiomers, diastereomers, or racemates thereof, for use in the treatment of low back pain (LBP) in a subject together with at least one standard of care (SoC) pain medication, or for improving the efficacy and/or reducing adverse effects of at least one SoC pain medication for treating LBP in a subject, wherein the CBD:THC weight ratio in the cannabinoid combination is about of 4:1 to about 10:1, preferably about 6:1.
7.WO/2020/181784MORINGA OLEIFERA LEAF EXTRACT HAVING URIC ACID LOWERING ACTIVITY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
WO 17.09.2020
Int.Class A61K 36/899
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
Appl.No PCT/CN2019/114166 Applicant SOUTH CHINA UNIVERSITY OF TECHNOLOGY Inventor LIN, Lianzhu
A moringa oleifera leaf extract having uric acid lowering activity, a preparation method therefor and an application thereof. An extraction method for the extract comprises: after performing microwave drying on fresh moringa oleifera leaves, crushing and sieving; performing reflux extraction by adopting water-ethanol; after centrifuging, performing pressure-reduction concentration on a supernatant to obtain an ethanol extract; after drying residuals, performing heat treatment by using an alkali-method, proteinase enzymolysis, high-speed centrifuging and residual removal, supernatant ultrafiltration and impurity removal, secondary proteinase enzymolysis, high-speed centrifuging, supernatant pressure-reduction concentration, ethanol precipitation and impurity removal, and secondary pressure-reduction concentration to obtain polypeptide substances; adding the ethanol extract and spraying and drying to obtain the moringa oleifera leaf extract.
8.WO/2020/181372COMPOSITIONS AND METHODS FOR INHIBITING GROWTH OF CARIES-, GINGIVITIS- AND HALITOSIS-CAUSING BACTERIA
WO 17.09.2020
Int.Class A61K 36/82
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
82Theaceae (Tea family), e.g. camellia
Appl.No PCT/CA2020/050317 Applicant DOSEBIOME INC. Inventor JIN, Ted
The invention provides compositions and methods for topically inhibiting, reducing or preventing growth or biofilm formation of caries-, gingivitis- and/or halitosis-causing bacteria. The composition includes at least about 0.005% (w/v) of tea polyphenols, a pH modulating agent for maintaining a pH of the composition above about 6.5, and at least about 1% (w/v) of a 3-carbon to a 24-carbon sugar alcohol. Also provided are food products or supplements incorporating such compositions.
9.WO/2020/182602FIBROUS MAIZE-BASED ANIMAL FEED WITH GH30 GLUCURONOXYLAN HYDROLASE
WO 17.09.2020
Int.Class A23K 10/12
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
KFEEDING-STUFFS SPECIALLY ADAPTED FOR ANIMALS; METHODS SPECIALLY ADAPTED FOR PRODUCTION THEREOF
10Animal feeding-stuffs
10obtained by microbiological or biochemical processes
12by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
Appl.No PCT/EP2020/055830 Applicant NOVOZYMES A/S Inventor DELLA PIA, Eduardo, Antonio
Improvement of the intestinal health of a monogastric animal by increasing the levels of cecal butyrate levels in situ in said animal by administering a GH30 glucuronoxylan hydrolase-enriched maize-based animal feed is described. Improving the feed conversion ratio of said animal feed is furthermore observed.
10.WO/2020/182822SAFFRON BULB EXTRACT FOR TREATING INFLAMMATIONS
WO 17.09.2020
Int.Class A61K 36/88
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
Appl.No PCT/EP2020/056373 Applicant TAGORA IP AG Inventor BOSSARD, Silvia
The invention relates to a composition containing a saffron bulb extract. The composition has an anti-inflammatory effect and is suitable for use as a medicament, for use in cosmetic products and as a food or food additive.